| 000 | 01705 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250513200511.0 | ||
| 264 | 0 | _c20000113 | |
| 008 | 200001s 0 0 eng d | ||
| 022 | _a0009-7322 | ||
| 024 | 7 |
_a10.1161/01.cir.100.25.2519 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGumina, R J | |
| 245 | 0 | 0 |
_aInhibition of the Na(+)/H(+) exchanger confers greater cardioprotection against 90 minutes of myocardial ischemia than ischemic preconditioning in dogs. _h[electronic resource] |
| 260 |
_bCirculation _c |
||
| 300 |
_a2519-26; discussion 2469-72 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 |
_aAmiloride _xanalogs & derivatives |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aDogs |
| 650 | 0 | 4 | _aDrug Evaluation, Preclinical |
| 650 | 0 | 4 |
_aGuanidines _xpharmacology |
| 650 | 0 | 4 | _aHemodynamics |
| 650 | 0 | 4 |
_aHydrogen _xmetabolism |
| 650 | 0 | 4 |
_aIon Transport _xdrug effects |
| 650 | 0 | 4 | _aIschemic Preconditioning, Myocardial |
| 650 | 0 | 4 |
_aMesylates _xpharmacology |
| 650 | 0 | 4 |
_aMuscle Proteins _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aMyocardial Infarction _xdrug therapy |
| 650 | 0 | 4 |
_aMyocardial Reperfusion Injury _xdrug therapy |
| 650 | 0 | 4 |
_aSodium _xmetabolism |
| 650 | 0 | 4 |
_aSodium-Hydrogen Exchangers _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aSulfones _xpharmacology |
| 700 | 1 | _aBuerger, E | |
| 700 | 1 | _aEickmeier, C | |
| 700 | 1 | _aMoore, J | |
| 700 | 1 | _aDaemmgen, J | |
| 700 | 1 | _aGross, G J | |
| 773 | 0 |
_tCirculation _gvol. 100 _gno. 25 _gp. 2519-26; discussion 2469-72 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1161/01.cir.100.25.2519 _zAvailable from publisher's website |
| 999 |
_c10560904 _d10560904 |
||